Novartis
NVS
NVS
939 hedge funds and large institutions have $23.3B invested in Novartis in 2015 Q1 according to their latest regulatory filings, with 83 funds opening new positions, 313 increasing their positions, 375 reducing their positions, and 51 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
5% more capital invested
Capital invested by funds: $22.3B → $23.3B (+$1.06B)
0.11% less ownership
Funds ownership: 9.77% → 9.67% (-0.11%)
17% less repeat investments, than reductions
Existing positions increased: 313 | Existing positions reduced: 375
Holders
939
Holding in Top 10
69
Calls
$43.8M
Puts
$31.2M
Top Buyers
| 1 | +$173M | |
| 2 | +$161M | |
| 3 | +$77.5M | |
| 4 |
Jennison Associates
New York
|
+$76.2M |
| 5 |
TCIM
TIAA CREF Investment Management
New York
|
+$67.7M |
Top Sellers
| 1 | -$171M | |
| 2 | -$138M | |
| 3 | -$125M | |
| 4 |
BTS
BB&T Securities
Richmond,
Virginia
|
-$88M |
| 5 |
WCM
Wedge Capital Management
Charlotte,
North Carolina
|
-$49.7M |